Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven P Balk

Showing results (71-80 of 189) with videos related to

Pageof 19
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Circulating myeloid dendritic cells of advanced cancer patients result in reduced activation and a biased cytokine profile in invariant NKT cellsHans J J van der Vliet, Ruojie Wang, Simon C Yue, et al.
Plos One|July 2, 2010
Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramideMichael Nowak, Mohammed S Arredouani, Adrian Tun-Kyi, et al.
Molecular Endocrinology (Baltimore, Md.)|October 2, 2012
In silico discovery of androgen receptor antagonists with activity in castration resistant prostate cancerHoward C Shen, Kumaran Shanmugasundaram, Nicholas I Simon, et al.
The Journal of Biological Chemistry|December 6, 2011
Androgen Receptor Enhances p27 Degradation in Prostate Cancer Cells through Rapid and Selective TORC2 ActivationZi Fang, Tao Zhang, Nishtman Dizeyi, et al.
Cancer Research|August 25, 2019
ZBTB7A Mediates the Transcriptional Repression Activity of the Androgen Receptor in Prostate CancerDong Han, Sujun Chen, Wanting Han, et al.
Science Signaling|May 30, 2013
Tyrosine kinase BMX phosphorylates phosphotyrosine-primed motif mediating the activation of multiple receptor tyrosine kinasesSen Chen, Xinnong Jiang, Christina A Gewinner, et al.
The Journal of Biological Chemistry|December 16, 2004
The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonistsMyles C Hodgson, Inna Astapova, Shinta Cheng, et al.
Molecular Cancer Therapeutics|October 3, 2025
Preclinical activity of the DLL3-targeted T cell engager MK-6070 in neuroendocrine prostate cancerSheng-Yu Ku, Nishat Manzar, Maria Mica Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2014
Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancerZiyang Yu, Sen Chen, Adam G Sowalsky, et al.
Chemico-Biological Interactions|December 17, 2014
The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancerDaniel Tamae, Elahe Mostaghel, Bruce Montgomery, et al.
Pageof 19

Showing results (71-80 of 189) with videos related to

Sort By:
Pageof 19
Journal of Immunology (Baltimore, Md. : 1950)|May 21, 2008
Circulating myeloid dendritic cells of advanced cancer patients result in reduced activation and a biased cytokine profile in invariant NKT cellsHans J J van der Vliet, Ruojie Wang, Simon C Yue, et al.
Plos One|July 2, 2010
Defective NKT cell activation by CD1d+ TRAMP prostate tumor cells is corrected by interleukin-12 with α-galactosylceramideMichael Nowak, Mohammed S Arredouani, Adrian Tun-Kyi, et al.
Molecular Endocrinology (Baltimore, Md.)|October 2, 2012
In silico discovery of androgen receptor antagonists with activity in castration resistant prostate cancerHoward C Shen, Kumaran Shanmugasundaram, Nicholas I Simon, et al.
The Journal of Biological Chemistry|December 6, 2011
Androgen Receptor Enhances p27 Degradation in Prostate Cancer Cells through Rapid and Selective TORC2 ActivationZi Fang, Tao Zhang, Nishtman Dizeyi, et al.
Cancer Research|August 25, 2019
ZBTB7A Mediates the Transcriptional Repression Activity of the Androgen Receptor in Prostate CancerDong Han, Sujun Chen, Wanting Han, et al.
Science Signaling|May 30, 2013
Tyrosine kinase BMX phosphorylates phosphotyrosine-primed motif mediating the activation of multiple receptor tyrosine kinasesSen Chen, Xinnong Jiang, Christina A Gewinner, et al.
The Journal of Biological Chemistry|December 16, 2004
The androgen receptor recruits nuclear receptor CoRepressor (N-CoR) in the presence of mifepristone via its N and C termini revealing a novel molecular mechanism for androgen receptor antagonistsMyles C Hodgson, Inna Astapova, Shinta Cheng, et al.
Molecular Cancer Therapeutics|October 3, 2025
Preclinical activity of the DLL3-targeted T cell engager MK-6070 in neuroendocrine prostate cancerSheng-Yu Ku, Nishat Manzar, Maria Mica Garcia, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2014
Rapid induction of androgen receptor splice variants by androgen deprivation in prostate cancerZiyang Yu, Sen Chen, Adam G Sowalsky, et al.
Chemico-Biological Interactions|December 17, 2014
The DHEA-sulfate depot following P450c17 inhibition supports the case for AKR1C3 inhibition in high risk localized and advanced castration resistant prostate cancerDaniel Tamae, Elahe Mostaghel, Bruce Montgomery, et al.
Pageof 19